Breaking News

India pharma forecast record growth for 2023

Scoring second only to the USA in ‘growth potential’ and ‘overall competitiveness’ in the CPHI Annual Survey

Want print copies of Manufacturing Chemist delivered to your door?

Catch up with Manufacturing Chemist in print, at your leisure

Poolbeg-led consortium awarded €2.3m in funding

Taking place over three years, the collaboration between Poolbeg Pharma, University College Dublin, Trinity College Dublin and AnaBio Technologies...

Can preventive care put an end to disease and virus outbreaks?

Healthcare shouldn’t be about treatment!

Piramal Pharma announces consolidated results for Q2 and H1 FY2023

Revenue from operation grew by 11% to INR 3,202 Cr. versus INR 2,889 Cr. in H1FY22

Catalent announces $12m expansion programme for Oral Solid Doses

In April 2022, Catalent announced the completion of an expansion project to increase capacity and capabilities for producing encapsulated oral soli...

Addressing the pharmaceutical industry’s energy blind spots

Paul Walsh, General Manager at CIM, explores the major energy consumption challenges facing the UK’s pharmaceutical manufacturing and life science...

Bringing biotech to the Baltics: the rise of Lithuania

Lithuania’s biotechnology competencies lie in cell and gene therapies, enzymes and the wider pharmaceutical industry, offering companies a rich poo...

CatSci invests in oligonucleotides production capability

Oligonucleotides are an emerging modality and an innovative technology offering new therapeutics opportunities to treat previously unmet patients’...

WuXi STA opens oral drug manufacturing facility

The new facility marks a milestone for WuXi STA, further extending its drug product capacity and capabilities to meet the growing demand for HP dru...

The legacy of COVID-19 on the pharmaceutical industry

Although the COVID-19 pandemic has by no means ended, many countries are now on the path to transitioning the virus to a state of endemicity. Yet,...

Beximco Pharma: The Bangladeshi company connecting with the US

COO Rabbur Reza talks about the strategy behind approaching pharmaceutical manufacturing from an emerging market

Teijin, J-TEC, Mitsui Fudosan and NCC establish regenerative medicine platform

The platform supports the development of innovative treatments for diseases with unmet needs such as cancer

Watered down profits

An innovative new approach to washdown and wastewater treatment creates an opportunity for pharmaceutical manufacturers, reports Mark Hardiman, CEO...

Stablepharma and Bul Bio sign agreement on Tetanus diphtheria vaccine

This agreement means that Stablepharma can progress and lead full development and registration of dry, thermostable versions of the Tetadif vaccine...

Remediating pharmaceutical quality systems

Much of our work involves helping companies remediate flawed quality systems. Find out the factors that can make your remediation project a success